Followers | 246 |
Posts | 49819 |
Boards Moderated | 63 |
Alias Born | 08/29/2007 |
Saturday, March 16, 2024 2:55:36 PM
I am writing a book, American Cars of 1958. Check often for the latest addition. https://investorshub.advfn.com/American-Cars-of-1958-37252/
Recent NXTC News
- NextCure Provides Business Update and Reports First Quarter 2024 Financial Results • GlobeNewswire Inc. • 05/02/2024 08:05:00 PM
- NextCure to Present Phase 1b Data of NC410 in Combination with Pembrolizumab at ASCO 2024 • GlobeNewswire Inc. • 04/24/2024 08:05:00 PM
- NextCure and LCB Present Preclinical Data on B7-H4 Antibody Drug Conjugate at AACR 2024 • GlobeNewswire Inc. • 04/08/2024 11:00:00 AM
- NextCure Appoints Dr. Rakesh Dixit to Scientific Advisory Board • GlobeNewswire Inc. • 04/04/2024 11:05:00 AM
- NextCure to Present at 23rd Annual Needham Virtual Healthcare Conference • GlobeNewswire Inc. • 04/02/2024 11:00:00 AM
- NextCure Provides Business Update and Reports Full Year 2023 Financial Results • GlobeNewswire Inc. • 03/21/2024 12:55:00 PM
- NextCure Publishes Preclinical Data Demonstrating Function of FLRT3 as a T Cell Inhibitor in Science Advances • GlobeNewswire Inc. • 03/05/2024 01:05:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/01/2024 09:45:59 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/01/2024 09:45:06 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/01/2024 09:44:41 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/01/2024 09:44:11 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/01/2024 09:43:45 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/01/2024 09:43:21 PM
- NextCure Presents Preclinical Data on a Novel Therapeutic Candidate Targeting VSTM-1 for the Treatment of Progressive Inflammatory Airway Disorders • GlobeNewswire Inc. • 01/18/2024 09:05:00 PM
- NextCure Publishes Non-Clinical Data Demonstrating Anti-Siglec-15 Treatment Prevented Bone Loss Due to Immobilization from Acute Spinal Cord Injury • GlobeNewswire Inc. • 12/21/2023 12:05:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/14/2023 12:15:59 PM
- NextCure Provides Year-End Clinical Pipeline Updates • GlobeNewswire Inc. • 12/14/2023 11:45:00 AM
- NextCure to Present at the 35th Annual Piper Sandler Healthcare Conference • GlobeNewswire Inc. • 11/20/2023 12:00:00 PM
- NextCure Publishes Non-Clinical Data Defining the Mechanism of Action for NC525, a Novel LAIR-1 Antibody for AML • GlobeNewswire Inc. • 11/15/2023 09:05:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/02/2023 08:20:28 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/02/2023 08:10:28 PM
- NextCure Provides Business Update and Reports Third Quarter 2023 Financial Results • GlobeNewswire Inc. • 11/02/2023 08:05:00 PM
- Preclinical Data Demonstrate Anti-Siglec-15 Treatment Reduced Bone Loss and Enhanced Bone Quality in Mice with Moderate-to-Severe Osteogenesis Imperfecta (OI) • GlobeNewswire Inc. • 10/17/2023 12:05:00 PM
- NextCure Presents Preclinical Data on NC181, a Novel Therapeutic Candidate Targeting ApoE4, for the Treatment of Alzheimer’s Disease • GlobeNewswire Inc. • 09/26/2023 08:05:00 PM
- A Phase 2 Study of Anti-Siglec-15 Antibody, NC318, in Combination with Pembrolizumab (NCT04699123) Demonstrates Clinical Activity in Patients with Advanced PD-1 Axis Inhibitor Refractory NSCLC • GlobeNewswire Inc. • 09/12/2023 12:05:00 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM